{"entity":{"type":"insider","cik":"0001648828","url":"/insider/0001648828","json_url":"/insider/0001648828.json","name":"Kusmierz Katarzyna","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2018-12-31","last":"2020-09-02","span_basis":"filed_date"},"name_variants":[{"name":"Kusmierz Katarzyna","source":"filing","n_filings":4,"first_seen":"2018-12-31","last_seen":"2020-09-02"}],"transactions":[{"id":2989511,"accession":"0001437749-20-019217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-019217","line_url":"/filing/0001437749-20-019217#line-1","is_derivative":false,"issuer_cik":"0000922247","issuer_name":"Cyclo Therapeutics, Inc.","issuer_ticker":"CTDH","issuer_name_source":null,"issuer_url":"/issuer/0000922247","owner_cik":null,"owner_name":"NOVIT, L.P.; Novit U.S., Inc.; Kusmierz Katarzyna","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000000.0,"shares_display":"10,000,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":21517582.0,"shares_owned_after_display":"21,517,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-27","filed_date":"2020-09-02","scope":"insider"},{"id":3298122,"accession":"0001437749-20-008574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-008574","line_url":"/filing/0001437749-20-008574#line-1","is_derivative":false,"issuer_cik":"0000922247","issuer_name":"Cyclo Therapeutics, Inc.","issuer_ticker":"CTDH","issuer_name_source":null,"issuer_url":"/issuer/0000922247","owner_cik":null,"owner_name":"Novit U.S., Inc.; Kusmierz Katarzyna; NOVIT, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","shares_owned_after":11517582.0,"shares_owned_after_display":"11,517,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-24","filed_date":"2020-04-27","scope":"insider"},{"id":8177846,"accession":"0001437749-19-011250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-011250","line_url":"/filing/0001437749-19-011250#line-1","is_derivative":false,"issuer_cik":"0000922247","issuer_name":"CTD HOLDINGS INC","issuer_ticker":"CTDH","issuer_name_source":null,"issuer_url":"/issuer/0000922247","owner_cik":null,"owner_name":"Kusmierz Katarzyna; NOVIT, L.P.; Novit U.S., Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":9517582.0,"shares_owned_after_display":"9,517,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-03","scope":"insider"},{"id":6565044,"accession":"0001437749-18-022771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-18-022771","line_url":"/filing/0001437749-18-022771#line-1","is_derivative":false,"issuer_cik":"0000922247","issuer_name":"CTD HOLDINGS INC","issuer_ticker":"CTDH","issuer_name_source":null,"issuer_url":"/issuer/0000922247","owner_cik":null,"owner_name":"Novit U.S., Inc.; Kusmierz Katarzyna; NOVIT, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":346154.0,"shares_display":"346,154","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":8717582.0,"shares_owned_after_display":"8,717,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-21","filed_date":"2018-12-31","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000922247","name":"Cyclo Therapeutics, Inc.","url":"/issuer/0000922247","role":"Ten percent owner","n_filings":4,"first_seen":"2018-12-31","last_seen":"2020-09-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001648828","retrieved_at":"2026-08-21T09:22:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}